Search Within

Sean McCarthy Devlin

Formats
  1. Meeting Abstract (375)
  2. Journal Article (219)
  3. Research Letter (16)
  4. Correspondence (5)
  5. Editorial (1)
  6. Review (1)
Groups
  1. Biostatistics Service (617)
  2. Epidemiology and Biostatistics (617)
  3. Department of Medicine (588)
  4. Hematologic Malignancies, Division of (587)
  5. Center for Hematologic Malignancies (585)
  6. Bone Marrow Transplant (470)

More Groups

People
  1. Sergio Giralt (380)
  2. Miguel-Angel Perales (303)
  3. Gunjan Shah (187)
  4. Molly Maloy (162)
  5. Parastoo Dahi (161)
  6. Michael Scordo (152)

More People

Years
  1. 2025 (19)
  2. 2024 (35)
  3. 2023 (52)
  4. 2022 (42)
  5. 2021 (36)
  6. 2020 (56)

More Years

Publications
  1. Blood (204)
  2. Biology of Blood and Marrow Transplantation (133)
  3. Bone Marrow Transplantation (51)
  4. Blood Advances (28)
  5. Transplantation and Cellular Therapy (25)
  6. Journal of Clinical Oncology (16)

More Publications

Publishers
  1. American Society of Hematology (232)
  2. Elsevier Inc. (176)
  3. Nature Publishing Group (74)
  4. American Society of Clinical Oncology (16)
  5. Taylor & Francis Group (16)
  6. American Association for Cancer Research (12)

More Publishers

Results (617)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A novel intermediate intensity conditioning regimen achieves high rates of long-term outpatient progression-free survival offsetting the disadvantage of early post-transplant complications in adult cord blood (CB) transplant recipients
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Mazis, C.; Maloy, M.; Scaradavou, A.; Dahi, P.; Perales, M. A.; Giralt, S. A.; Ponce, D. M.; Barker, J. N.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Immune-mediated hemolytic anemia (IMHA) and immune thrombocytopenia (ITP) after ex-vivo CD34+ selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Kosuri, S.; Adrianzen Herrera, D. A.; Hsu, M.; Devlin, S. M.; Maloy, M.; Nieves, J.; Borrill, T.; Avecilla, S. T.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Early toxicities associated with radiation based conditioning for relapsed/refractory Hodgkin lymphoma patients undergoing high dose therapy and autologous stem cell transplantation (HDT-ASCT)
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Devlin, S. M.; Yahalom, J.; Matasar, M. J.; Moskowitz, A.; Giralt, S. A.; Moskowitz, C. H.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Comparable survival with organ toxicity predicting for overall survival (OS) and non-relapse mortality (NRM) in older adult patients after CD34+ selected allogeneic hematopoietic stem cell transplantation (Allo-HCT)
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Kosuri, S.; Adrianzen Herrera, D. A.; Cho, C.; Maloy, M.; Nieves, J.; Devlin, S. M.; Borrill, T.; Carlow, D.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Using HapLogic™ & recipient ancestry: The likelihood of identifying an 8/8 HLA-matched unrelated donor can be accurately predicted at the time of the preliminary search markedly improving search efficiency & speed to allograft: An 830 patient analysis
    Meeting Abstract

    Davis, E.; Devlin, S. M.; Cooper, C.; Nhaissi, M.; Paulson, J.; Wells, D. S.; Scaradavou, A.; Giralt, S. A.; Papadopoulos, E. B.; Kernan, N. A.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Application of the CIBMTR Survival Outcomes Calculator to CD34-selected allogeneic HCT for acute leukemia and myelodysplastic syndrome
    Meeting Abstract

    Cho, C.; Devlin, S. M.; Maloy, M.; Horowitz, M. M.; Rizzo, J. D.; Giralt, S. A.; Perales, M. A.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Romiplostim for chemotherapy-induced thrombocytopenia (CIT). Results of a phase 2 trial
    Meeting Abstract

    Soff, G. A.; Miao, Y.; Devlin, S. M.; Mantha, S.; Mones, J. V.; Li, V. J.; Abou-Alfa, G. K.; Cercek, A.; Kemeny, N.; Parameswaran, R.
    Blood (2017)

    Fulltext@MSK | Save
  • Feasibility, tolerability, and patient-reported outcomes with pharmacokinetic (PK)-directed dosing of Evomela (propylene glycol free melphalan) for multiple myeloma and AL amyloidosis patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S. J.; Hoover, E.; Chung, D. J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with autologous hematopoietic stem cell transplant (AHCT) for multiple myeloma and AL amyloidosis
    Meeting Abstract

    Shah, G. L.; Landau, H.; Sarubbi, C.; Schofield, R.; Lin, A.; Bhatt, V.; Harnicar, S. J.; Devlin, S. M.; Chung, D. J.; Dahi, P. B.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Long-term follow-up of adult double unit cord blood (CB) transplantation (dCBT) recipients reveals high rates of progression-free survival after a novel cy/flu/thio/TBI 400 intermediate intensity conditioning regimen
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Jacob, A.; Maloy, M.; Mazis, C.; Naputo, K.; Scaradavou, A.; O'Reilly, R.; Avecilla, S.; Castro-Malaspina, H. R.; more...
    Blood (2017)

    Fulltext@MSK | Save